Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M107,485Revenue $M19,960Net Margin (%)8.9Altman Z-Score3.8
Enterprise Value $M110,813EPS $1.1Operating Margin %18.3Piotroski F-Score7
P/E(ttm)60.8Beneish M-Score-2.9Pre-tax Margin (%)12.1Higher ROA y-yN
Price/Book78.610-y EBITDA Growth Rate %--Quick Ratio1.3Cash flow > EarningsY
Price/Sales5.35-y EBITDA Growth Rate %--Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow28.4y-y EBITDA Growth Rate %-43.2ROA % (ttm)6.5Higher Current Ratio y-yN
Dividend Yield %2.7PEG--ROE % (ttm)51.4Less Shares Outstanding y-yY
Payout Ratio %155Shares Outstanding M1,594ROIC % (ttm)28.6Gross Margin Increase y-yY

Gurus Latest Trades with ABBV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABBVNWQ Managers 2015-03-31 Add1.27%$55.48 - $67.63
($60.41)
$ 67.2411%Add 1815.34%1,839,012
ABBVJoel Greenblatt 2015-03-31 Add0.25%$55.48 - $67.63
($60.41)
$ 67.2411%Add 6238.89%555,223
ABBVFirst Eagle Investment 2015-03-31 Sold Out -0.16%$55.48 - $67.63
($60.41)
$ 67.2411%Sold Out0
ABBVDavid Dreman 2015-03-31 Buy 0.05%$55.48 - $67.63
($60.41)
$ 67.2411%New holding9,655
ABBVKen Fisher 2015-03-31 Add$55.48 - $67.63
($60.41)
$ 67.2411%Add 0.96%1,010,756
ABBVMario Gabelli 2015-03-31 Add$55.48 - $67.63
($60.41)
$ 67.2411%Add 36.62%47,212
ABBVDodge & Cox 2015-03-31 Reduce$55.48 - $67.63
($60.41)
$ 67.2411%Reduce 7.88%35,055
ABBVJohn Paulson 2014-12-31 Sold Out -3.1%$52.9 - $69.71
($63.24)
$ 67.246%Sold Out0
ABBVSteve Mandel 2014-12-31 Sold Out -1.2%$52.9 - $69.71
($63.24)
$ 67.246%Sold Out0
ABBVGeorge Soros 2014-12-31 Sold Out -0.66%$52.9 - $69.71
($63.24)
$ 67.246%Sold Out0
ABBVFirst Eagle Investment 2014-12-31 Buy 0.16%$52.9 - $69.71
($63.09)
$ 67.247%New holding1,016,097
ABBVMario Gabelli 2014-12-31 Add0.01%$52.9 - $69.71
($63.09)
$ 67.247%Add 232.85%34,557
ABBVJohn Paulson 2014-09-30 Buy 3.1%$52.05 - $59.62
($55.51)
$ 67.2421%New holding13,000,000
ABBVSteve Mandel 2014-09-30 Buy 1.2%$52.05 - $59.62
($55.51)
$ 67.2421%New holding5,247,201
ABBVGeorge Soros 2014-09-30 Add0.6%$52.05 - $59.62
($55.51)
$ 67.2421%Add 924.76%1,537,146
ABBVJoel Greenblatt 2014-09-30 Reduce-0.06%$52.05 - $59.62
($55.51)
$ 67.2421%Reduce 89.36%9,460
ABBVJoel Greenblatt 2014-06-30 Reduce-0.11%$46.46 - $56.79
($52.4)
$ 67.2428%Reduce 61.19%88,923
ABBVGeorge Soros 2014-06-30 Reduce-0.1%$46.46 - $56.79
($52.4)
$ 67.2428%Reduce 57.14%150,000
ABBVKen Fisher 2014-06-30 Add0.06%$46.46 - $56.79
($52.4)
$ 67.2428%Add 76.13%1,104,609
ABBVNWQ Managers 2014-06-30 Buy 0.05%$46.46 - $56.79
($52.4)
$ 67.2428%New holding83,878
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABBV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABBV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HURWICH THOMAS A.VP, Controller 2015-05-19Sell6,200$662.09view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell8,281$64.923.79view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell64,232$64.843.92view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell102,964$64.674.19view
RICHMOND TIMOTHY J.SVP, Human Resources 2015-03-02Sell14,388$60.3311.69view
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC 2015-03-02Sell25,000$60.311.74view
HURWICH THOMAS A.VP, Controller 2015-02-27Sell1,185$60.5711.24view
SALEKI-GERHARDT AZITASVP, Operations 2015-02-27Sell2,112$60.4711.43view
RICHMOND TIMOTHY J.SVP, Human Resources 2015-02-17Sell241$58.714.79view
CHASE WILLIAM JEVP, CFO 2014-12-22Sell8,495$68-0.91view

Press Releases about ABBV :

    Quarterly/Annual Reports about ABBV:

    News about ABBV:

    Articles On GuruFocus.com
    Abbvie Inc. Dividend Stock Analysis May 26 2015 
    Scott Black's Most Heavily Weighted Trades In Q1 2015 May 21 2015 
    Risk & Reward with Gilead Sciences Inc. (GILD) May 14 2015 
    8 Top Healthcare Stocks to Watch May 13 2015 
    AbbVie Floats Mega-Bond Deal For Acquisition Funding May 08 2015 
    Pharmacyclics Posts A Mixed First Quarter Ahead Of Being Acquired By AbbVie May 07 2015 
    AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board Apr 24 2015 
    Analyzing Chris Davis' Top Holdings Apr 14 2015 
    Gilead Experiencing Bumpy Ride Despite Strong Fundamentals Apr 03 2015 
    AbbVie Strikes The Biggest Deal For Treatment Of Cancer Mar 10 2015 

    More From Other Websites
    IBD Market Wrap - 05/27/15 May 27 2015
    AbbVie Is Buying Back $5 Billion in Stock. Hurray? May 27 2015
    AbbVie (ABBV) Stock Gains on Bullish JPMorgan Note May 27 2015
    JPMorgan: Buy AbbVie, Low Valuation Belies EPS Growth Potential May 27 2015
    AbbVie Accelerates Share Buybacks May 27 2015
    ABBVIE INC. Files SEC form 8-K, Other Events May 27 2015
    AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and... May 26 2015
    Enanta Announces SVR12 results of 95% from AbbVie’s GIFT-1 Study in Non-cirrhotic, Japanese... May 26 2015
    AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and... May 26 2015
    NWQ's First-Quarter Buys and Adds Affect Portfolio May 26 2015
    Ambarella Leads 3 Top Stocks Bucking The Sell-Off May 26 2015
    Jim Cramer -- Here's Why I'm Buy, Buy, Buying J&J and Selling Merck May 26 2015
    This Medical Stock Refuses To Fall With Major Stock Indexes May 26 2015
    AbbVie (ABBV) Stock Gains After Completing $21 Billion Pharmacyclics Purchase May 26 2015
    Abbvie completes $21 billion buyout of Pharmacyclics May 26 2015
    Abbvie completes $21 billion buyout of Pharmacyclics May 26 2015
    ABBVIE INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Other Events,... May 26 2015
    AbbVie Completes Acquisition of Pharmacyclics May 26 2015
    8:33 am AbbVie closes Pharmacyclics (PCYC) acquisition;... May 26 2015
    AbbVie Completes Acquisition of Pharmacyclics May 26 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK